Screener
Ironwood Pharmaceuticals IRWD Business Segments
| Q2 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|
| Revenue From Contract With Customer Excluding Assessed Tax Net by Product | |||||
| Collaborative Arrangement Development And Commercialization Agreements | $540K+120% | —— | —— | -$2.7M— |
FAQ
- How does Ironwood Pharmaceuticals break its business down?
- Ironwood Pharmaceuticals (IRWD) reports revenue from contract with customer excluding assessed tax net by product across 2 parts — Collaborative Arrangement Co Promotion Agreement and Collaborative Arrangement Development And Commercialization Agreements. Each is extracted from the segment footnotes and tracked over time.
- Where does Ironwood Pharmaceuticals's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Ironwood Pharmaceuticals's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
